GILD Stock DD Gilead Sciences, Inc. 08/21/2014 01:15:46

New Post Public Reply Private Reply Replies (0) Message Board

Aug 21, 2014 at 2:15 AM

GILD Gilead Sciences, Inc. $GILD Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

Last Updated: 08/21/2014 01:15:41

Current Price and Quotes
Last Price 100.79
Previous Close 101.28 Open 100.71
Daily Range 100.61 - 102.57 52wk Range 57.31 - 101.64
Volume 12,592,454 Dividend N/A
Average Vol (30d) 12,970,263 Yield N/A

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 11,201,688 9,702,517 8,385,385 7,949,420
Cost of Revenue 2,858,502 2,471,363 2,124,410 1,869,876
Gross Profit 8,343,186 7,231,154 6,260,975 6,079,544
Operating Expenses

Research and Development 2,119,756 1,759,945 1,229,151 1,072,930
Sales, General and Admin. 1,699,431 1,461,034 1,241,983 1,044,392
Non-Recurring Items - - - -
Other - - - -
Operating Income 4,523,999 4,010,175 3,789,841 3,962,222
Income From Continuing Operations

Add'l Income/Expense Items (8,886) (37,279) 66,581 60,287
Earnings Before Interest and Tax 4,515,113 3,972,896 3,856,422 4,022,509
Interest Expense 306,894 360,916 205,418 108,961
Earnings Before Tax 4,208,219 3,611,980 3,651,004 3,913,548
Income Tax 1,150,933 1,038,381 861,945 1,023,799
Minority Interest (17,522) (17,967) (14,578) (11,508)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 3,074,808 2,591,566 2,803,637 2,901,257
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 3,074,808 2,591,566 2,803,637 2,901,257
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 3,074,808 2,591,566 2,803,637 2,901,257

Recent News

Aug 19, 2014 Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana
Aug 14, 2014 Zacks.com featured expert Kevin Matras highlights: Gilead Sciences, LyondellBasell, Magna Int'l, RF Micro Devices and United Continental Holdings.
Aug 13, 2014 Gilead Sciences,Melco Crown Entertainment,Banco Santander, BarclaysandDeutsche Bankhighlighted as Zacks Bull and Bear of the Day
Aug 11, 2014 The Zacks Analyst Blog Highlights: Natural Gas Services, Sanmina, Green Dot, Gilead Sciences and Verizon
Aug 8, 2014 Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health
Aug 7, 2014 Zacks Earnings Trends Highlights: Intel, Micron Technology, Apple, Gilead Sciences and Verizon
Aug 4, 2014 Critical Alerts For Groupon, Gilead Sciences, Ballard Power Systems, GlaxoSmithKline, and Eli Lilly Released By InvestorsObserver
Aug 3, 2014 Doctor Evidence Partnering with Healthcare Decision-Makers on Hepatitis C Evidence
Jul 31, 2014 Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis
Jul 31, 2014 Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences

1
2
3
4
5
next >

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Raken Debuts Change Orders: A Game-Changer for Builds

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Ardelyx Securities Fraud Suit: Key Investor Moves

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Lupin Secures FDA Nod for Key Injectable Drug

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

PrideStaff: 8 Years Strong on Franchise Times Top 400

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

CME Group Unveils First Baseball Futures Market

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Webull Faces Legal Scrutiny Over Chinese Ties

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Newfold Digital Revamps Leadership for Growth Surge

Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...

Ajman Tourism Department Hits Internal Audit Milestone

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Hexaware Teams with Anthropic for Game-Changing AI Move

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Full Sail University Bags Billboard Music School Honor

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...